Effect of Caffeine on Serum Tumour Necrosis Factor Alpha and Lactate Dehydrogenase in Wistar Rats Exposed to Cerebral Ischaemia-reperfusion Injury
##semicolon##
Caffeine##common.commaListSeparator## ischaemia-reperfusion injury##common.commaListSeparator## cerebral ischaemia##common.commaListSeparator## neuro-inflammation##common.commaListSeparator## stroke##article.abstract##
Summary: Caffeine is known to confer neuro-protection via A1 and A2A adenosine receptor antagonism in which adenosine neuro-modulates excitotoxic release of glutamate. Currently, it is unclear whether caffeine modulates inflammation in ischaemic stroke model. The present study examined effects of caffeine following ischaemia-reperfusion injury on neuro-inflammatory tumour necrosis alpha (TNF-α), lactate dehydrogenase (LDH), as well as effect of caffeine against brain ischaemic damage on histology. Thirty three adult male Wistar rats (180-300 g) were used in this study. They were randomly divided into four groups (n=5 each): Group I (Control) that received neither the operation nor any treatment; Group II (Sham/Water) received a pseudo-ischaemic-reperfusion and 1ml water for injection; Group III (BCCO/Water) that received complete bilateral common carotid occlusion (BCCO) and 1ml water for injection; Group IV (BCCO/Caffeine) that received complete BCCO and caffeine solution intraperitoneally at a dose of 50% LD50 value (144mg/kg); and thirteen rats were used for LD50 assessment. Sensory and motor functions significantly (p<0.05) decreased in the rat following ischaemia-reperfusion injury when compared to pre-injury state on Garcia neurological score. Caffeine reduced brain ischaemic injury and significantly reduced (p<0.05) TNF-α activity. While no significant effects (p>0.05) of caffeine was observed on LDH activity. This study has shown neuro-protective roles of caffeine against ischaemia-reperfusion damage to brain tissue, inflammatory TNF-α activity, but not on LDH activity
##submission.citations##
Acheson, K.J., Gremaud, G., Meirim, I., Montigon, F., Krebs, Y., Fay, L.B., Gay, L.G., Schneiter, P., Schindler, C. and Tappy, L. (2004). Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? American Journal of Clinical Nutrition, 79: 40-46.
Akhila, S.J., Deepa, S.S. and Alwan, V. (2007). Acute toxicity and determination of median lethal dose. Current Science 93(7): 917-920.
Alexander, M., Smith, A.L., Rosenkrantz, T.S. and Fitch, R.H. (2013). Therapeutic effect of caffeine treatment immediately following neonatal hypoxic-ischemic injury on spatial memory in male rats. Brain Science 3: 177-190.
Astrup, A., Toubro, S., Cannon, S., Hem, P., Breum, L. and Madsen, J. (1990). Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. American Journal of Clinical Nutrition, 51: 759-767.
Aytac, E., Seymen, H.O., Uzun, H., Dikmen, G. Altug, T. (2006). Effects of iloprost on visual evoked potentials and brain tissue oxidative stress after bilateral common carotid artery occlusion. Prostaglandins, Leukotrienes and Essential Fatty Acids, 74; 373-378.
Belza, A., Toubro, S. and Astrup, A. (2009). The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. European Journal of Clinical Nutrition , 63: 57-64.
Bona, E., Aden, U., Fredholm, B.B. and Hagberg, H. (1995). The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate. Pediatric research 38(3): 312-318.
Brothers, H.M., Marchalant, Y. Wenk, G.L. (2010). Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neuroscience Letters, 480: 97–100. Cai, M., Ma, Y., Zhang, W., Wang, S., Wang, Y., Tian, L., Peng, Z., Wang, H. and Qingrong, T. (2016). Apigenin-7-O-β-D-(-6''-p-coumaroyl)-Glucopyranoside treatment elicits neuroprotective effect against experimental ischemic stroke. International Journal of Biological Sciences, 12(1): 42-52. Chatterjee, S. (2014). Artefacts of Histopathology. J Oral Maxillofac Pathol 18(1): 111-116.
Chen, J.F. and Pedata, F. (2008). Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors. Curr Pham Des 14(15): 1490-1499.
Chen,J., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D., Moskowitz, M.A., Fink, J.S. and Schwarzschild, M.A. (1999). A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. Journal of Neuroscience 19(21): 9192-9200.
Cimarosti, H., Siqueira, I.R., Zamin, L.L., Nassif, M., Balk, R., Frozza, R., Dalmaz, C., Netto, C.A. and Salbego, C. (2005). Neuroprotection and protein damage prevention by estradiol replacement in rat hippocampal slices exposed to oxygen-glucose deprivation. Neurochemical Research, 30(4): 583–589.
Dai, S., Zhou, Y., An, J., Li, P., Yang, N., Chen, X., Xiong, R., Liu, P., Zhao, Y., Shen, H., Zhu, P. and Chen, J. (2010). Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. Journal of Neuroscience 30(16):5802-5610.
Denes, A., Thornton, P., Rothwell, N.J. and Allan, S.M. (2010). Inflammation and brain injury: Acute cerebral ischaemia, peripheral and central inflammation. Brain, Behavior, and Immunity, 24: 708-723.
Desland, F.A., Afzal, A., Warraich, Z. and Mocco, J. (2014). Manual versus automated rodent behavioral assessment: comparing efficacy and ease of Baderson and Garcia neurological deficit scores to an open field video tracking system. J Cent Nerv Syst, 6: 7-14.
Douven, E., Schievink, S., Verhey, F., Oostenbrugge, R., Aalten, P., Staals, J. and Kohle, S. (2016). The cognition and affect after stroke – a prospective evaluation of risks (CASPER) study: rationale and design. BMC Neurology, 16(65): 1-11.
Erez, A., Shental, O., Tchebiner, J.Z., Laufer-Perl, M., Wasserman, A., Sella, T. and Guzner-Gur, H. (2014). Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients. IMAJ, 16: 439-443.
Ewen, T., Qiuting, L., Chaogang, T., Tao, T., Jun, W., Liming, T. and Guanghong, X. (2013). Neuro-protective effect of atorvastatin involves suppression of TNF-α and upregulation of IL-10 in a rat model of intra-cerebral haemorrhage. Cell Biochemistry and Biophysics, 66(2):337-346.
Fredholm, B.B., Ijzerman, A.I., Jacobson, K.A., Klotz, K. Linden, J. (2001). International union of pharmacology (XXV) nomenclature and classification of adenosine receptors. Pharmacological Review 53: 527-552.
Garcia, J.H., Wagner, S., Liu, K. and Hu, X. (1995). Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke, 26: 627-635.
Gong, H., Shu, L., Xu, H., Chen, B., Mao, R., Zhang, F. and Wang, Y. (2013). Bilateral internal carotid arteries ligation temporary impairs brain vasculaturev in young rats. Autonomic Neuroscience: Basic and Clinical, 173: 39-44.
Graham, E.M., Burd, I., Everett, A.D. and Northington, F.J. (2016). Blood biomarkers for evaluation of perinatal encephalopathy. Frontiersin Pharmacology, 7(196): 1-12.
Guan, Y., Jin, X., Guan, L., Yan, H., Wang, P., Gong, Z., Li, S., Cao, X. and Xing, Y. (2015). Nicotine inhibits microglial proliferation and is neuro-protective in global ischemia rats. Molecular Neurobiology, 51(3): 1480-1488.
Han, J.U., Lee, E., Moon, E., Ryu, J.H., Choi, J.W. and Kim, H. (2016). Matrix metalloproteinase-8 is a novel pathogenetic factor in focal cerebral ischemia. Molecular Neurology, 53(1): 231-239.
Hong, S., Gibney, G.T., Esquilin, M., Yu, J. and Xia, Y. (2004). Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxia. Brain Research, 1009(1): 195-202.
Huang, D., Hubbard, C.J. and Jungmann, R.A. (2009). Lactate dehydrogenase A subunit messenger RNA stability is synergistically regulated via the protein kinase A and C signal transduction pathways. Molecular Endocrinology, 9(8): 888-889.
Hurtado, O., Moro, M.A., Cardenas, A., Sanchez, V., Fernandez-Tome, P., Leza, J.C., Lorenzo, P., Secades, J.J., Lozano, R., Davalos, A., Castillo, J. and Lizasoaina, I. (2005). Neuro-protection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiology of Disease, 18: 336-345.
Joy, J.M., Vogel, R.M., Moon, J.R., Falcone, P.H., Mosman, M.M. and Kim, M.P. (2016). Twelve weeks supplementation with an extended-release caffeine and ATP enhancing supplement may improve body composition without affecting hematology in resistance-trained men. Journal of the International Society of Sports Nutrition, 13(25): 1-11.
Kagiyama, T., Glushakov, A.V., Sumners, C., Roose, B., Dennis, D.M., Phillips, M.I., Ozcan, M.S., Seubert, C.N. and Martynyuk, A.E. (2004). Neuroprotective action of halogenated derivatives of L-phenylalanine. Stroke, 35: 1192-1196.
Kalogeris, T., Bao, Y. and Korthuis, R.J. (2014). Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol, 2: 702–714.
Kanga, C., Jayasooriyaa, R.G., Dilsharaa, M.G., Choib, Y.H., Jeongc, Y., Kimd, N.D. and Kima, G. (2012). Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-kB activation and ERK phosphorylation. Food and Chemical Toxicology, 50: 4270-4276.
Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J., Morris, C.R., Nichols, J.S., Wang, X., Poljakovic, M., Sidney, M., Morris, J. and Gladwin, M.T. (2006). Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood, 107(6): 2279-2285.
Kim, K., Heo, M., CHun, Jun, H., Lee, J., Jegal, H and Yang Y. (2015). The relationship between stroke and quality of life in Korean adults: based on the 2010 Korean community health survey. J. Phys. Ther. Sci. 27: 309-312.
Lorke, D. (1983). A new approach to practical acute toxicity testing. Arch Toxicol, 54:275-287.
Marchi, M., Raiteri, L., Risso,F., Vallarino,A., Bonfanti,A., Monopoli,A., Ongini,E. and Raiteri, M. (2002). Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. British Journal of Pharmacology, 136(3): 434-440.
Margaritescu, O., Mogoanta, L., Pirici, I., Pirici, D., Cernea, D and Margaritescu, C.L. (2009), Histopathological changes in acute ischemic stroke. Romanian Journal of Morphology and Embryology, 50(3): 327-339.
Melani, A., Cipriani, S., Giuliana M.V., Daniele Nosi, Donati, C., Bruni, P., Grazia, M.G. and Pedata, F. (2009). Selective adenosine A2A receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia. Brain, 132: 1480-1495.
Mena, H., Cadavid, D., and Rushing, E.J. (2004). Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathologica, 108(6): 524-530.
Mohamed, R.A., Agha, A.M. Nassar, N.N. (2012). SCH58261 the selective adenosine A2A receptor blocker modulates ischemia reperfusion injury following bilateral carotid occlusion: role of inflammatory mediators. Neurochem Res, 37: 538-547.
Muhammad, M., El-ta’alu, A.B. and Mabrouk, M.I. (2016).: Pathogenesis and neuro-protective agents of stroke. Int J Pharm Sci Res, 7(10): 3907-16
Nehlig, A. (2002). Pharmacological properties and neurophysiological effects of caffeine. Pharmacopsychoecologia, 15: 35-70.
Piskunov, A.K. (2010). Neuroinflammation Biomarkers. Neurochemical Journal, 4(1): 55-63.
Ram, M., Begum, N., Pathakala, N. and Bakshi, V. (2016). Neuroprotective effect of Nevirapine on cerebral ischaemic stroke by middle cerebral artery occlusion in wistar rats. International Journal of Applied Pharmaceutical Sciences and Research, 1(1): 16-24.
Ravikumar, S., Surekha, R., and Thavarajah, R. (2014). Mounting media: An overvieaw. Journal of NTR University of Health Sciences, 3(1): 1-8.
Richard, A., Jungmann, and Kiryukhina, O. (2005). Cyclic AMP and AKAP-mediated targeting of protein kinase A regulates lactate dehydrogenase subunit A mRNA stability. The Journal of Biological Chemistry, 280(26): 25170-25177.
Rudolphi, K.A., Keil, M.J. Fredholm, B.B. (1989). Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neuroscience Letters 103(3): 275-280.
Schmidt-Kastnera, R., Aguirre-Chena, C., Saula, I., Yicka, L., Hamasakib, D., Bustoa, R. and Ginsberga, M.D. (2005). Astrocytes react to oligemia in the forebrain induced by chronic bilateral common carotid artery occlusion in rats. Brain Research, 1052: 28-39.
Sedger, L.M. McDermottc, M.F. (2014). TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future. Cytokine & Growth Factor Reviews, 25: 453–472.
Seetapun, S., Yaoling, J., Wang, Y. and Zhu, Z. (2013). Neuroprotective effect of Danshensu derivatives as anti-ischaemia agents on SH-SY5Y cells and rat brain. Biosci Rep, 33: 677-688.
Simats, A., García-Berrocoso, T. and Montaner, J. (2015). Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy. Biochimica et Biophysica Acta, 4: 1-14.
Tikka, T., Fiebich, B.L.,Goldsteins, G., Keinanen, R. and Koistinaho, J. (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. The Journal of Neuroscience, 21(8): 2580-2588.
Wang, Y., Reis, C., Applegate, R., Stier, G., Martin, R. and Zhang, J. (2015). Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke. Experimental Neurology, 1-15.
Wardas, J. (2002). Neuroprotective role of adenosine in the CNS. Polish Journal of Pharmacology, 54: 313–326.
Woodruff, T.M., Thundyil, J., Tang,S., Sobey, C.G., Taylor, S.M. and Arumugam, T.V. (2011). Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Molecular Neurodegeneration, 6(11): 1-19.
Yang, Z., Wang, B., Kwansa, H., Heitmiller, K.D., Hong, G., Carter, E.L., Jamrogowicz, J.L., Larson, A.C., Lee J Martin, L.J. and Koehler, R.C. (2013). Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet. Journal of Cerebral Blood Flow & Metabolism, 33: 1612-1620.
Yu, H., Hsieh, P., Chang, Y., Chung, P., Kuo, L. and Hwang, T. (2009). DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats. Biochemical Pharmacology, 78: 983–992.
Yuan, Y., Zha, H., Ramgarajan, P., Ling, E. and Wu, C. (2014). Anti inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia. BMC Neuroscience, 15: 125-133. Zarruk, J.G., García-Yebenes, I., Romera, V.G., Ballesteros, I., Moraga, A., Cuartero, M.I., Hurtado, O., Sobrado, M., Pradillo, J.M., Fernandez-Lopez, D., Serena, J., Castillo-Melendez, M., Moro, M.A. and Lizasoain, I. (2011). Neurological tests for functional outcome assessment in rodent models of ischaemic stroke. Rev Neurol, 53(10): 607-618.
